Novel Mitotic Checkpoint Gene
Inventor(s)
Daniel Scolnick
Tech ID
HT99001
Key Words
Cancer, Diagnostic, drug development target, gene therapy, screening tool, Therapeutic
Applications and Advantages
Since abnormal chfr is found only in cancer cells, it may be a target for development of new therapeutic agents or for gene therapy. Additionally, detection of chfr mutations may be useful for identifying cancers that are sensitive to certain chemotherapeutic agents, such as taxol.
Intellectual Property Status
U.S. Patent No. 7,176,293.
Licensing Opportunity
This technology is available for licensing on a nonexclusive basis.
